Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole prophylaxis for invasive pulmonary aspergillosis in AML patients receiving chemotherapy
TCTR20260301004Phase 4Completed
- Sponsor
- Siam Pharmaceutical
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of voriconazole in Acute Invasive Aspergillosis, sponsored by Siam Pharmaceutical. Started Dec 2024; status: completed.
02
Drugs
voriconazole
03
Conditions
Acute Invasive Aspergillosis
Beyond the preview
Go deeper on TCTR20260301004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260301004.